bioRxivBiophysicsPreprint
Map of SARS-CoV-2 spike epitopes not shielded by glycans.
M. Sikora, S. von Bülow, F. E. C. Blanc, M. Gecht, R. Covino, G. Hummer
Abstract
The severity of the COVID-19 pandemic, caused by the SARS-CoV-2 coronavirus, calls for the urgent development of a vaccine. The primary immunological target is the SARS-CoV-2 spike (S) protein. S is exposed on the viral surface to mediate viral entry into the host cell. To identify possible antibody binding sites not shielded by glycans, we performed multi-microsecond molecular dynamics simulations of a 4.1 million atom system containing a patch of viral membrane with four full-length, fully glycosylated and palmitoylated S proteins. By mapping steric accessibility, structural rigidity, sequence conservation and generic antibody binding signatures, we recover known epitopes on S and reveal promising epitope candidates for vaccine development. We find that the extensive and inherently flexible glycan coat shields a surface area larger than expected from static structures, highlighting the importance of structural dynamics in epitope mapping.Competing Interest StatementThe authors have declared no competing interest.View Full Text
- organism: virus
- assay: structural biology
- research focus: host-pathogen & immune response
- approach: biophysical modeling
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structure, Dynamics, Receptor Binding, and Antibody Binding of Fully-glycosylated Full-length SARS-CoV-2 Spike Protein in a Viral Membrane
Y. K. Choi, Y. Cao, … W. Im·bioRxiv·Oct 18, 2020
- Beyond Shielding: The Roles of Glycans in SARS-CoV-2 Spike Protein
L. Casalino, Z. Gaieb, … R. E. Amaro·bioRxiv·Jun 11, 2020
- Exploring dynamics and network analysis of spike glycoprotein of SARS-COV-2
M. Ghorbani, B. R. Brooks, J. B. Klauda·bioRxiv·Sep 28, 2020
- Energetics based epitope screening in SARS CoV-2 (COVID 19) spike glycoprotein by Immuno-informatic analysis aiming to a suitable vaccine development.
A. Banerjee, D. Santra, S. Maiti·bioRxiv·Apr 2, 2020
- Predicting the feasibility of targeting a conserved region on the S2 domain of the SARS-CoV-2 spike protein
P. Garg, S. C. C. Hsueh, S. S. Plotkin·bioRxiv·Mar 5, 2023
- The answer lies in the energy: how simple atomistic molecular dynamics simulations may hold the key to epitope prediction on the fully glycosylated SARS-CoV-2 spike protein
S. Serapian, F. Marchetti, … G. Colombo·bioRxiv·Jul 22, 2020